Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer

Study ID
NCT02567253

Study type
Interventional

Study phase
Phase 2

Study status
Completed

Trial Acronym

OvIP1

Trial Summary

The OvIP1 study is designed to examine how drug dose and perfusion temperature affect the pharmacokinetics and pharmacodynamics of cisplatin used as (hyperthermic) intraperitoneal chemoperfusion, as an adjunct to surgery, in women with stage III epithelial ovarian cancer.

More informations

Trial Starting Date

Mar 31,2016

Requirements

Gender Female
Minimum age 18 Years
Maximum age N/A

Enrollement Limit